AYLAAyala Pharmaceuticals Inc
Mkt Cap
$7.46MVolume
0.0052W High
$7.1352W Low
$0.3568PE Ratio
-0.20AYLA Fundamentals
Price
$0.4758Prev Close
$0.4758Open
$0.525350D MA
$0.5277Beta
0.61Avg. Volume
41,783.71EPS (Annual)
-$4.83P/B
0.88Rev/Employee
$9,952.38Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Ayalaâ??s approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations. The company has two product candidates under development, AL101 and AL02, targeting the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat a variety of tumors including Adenoid Cystic Carcinoma, Triple Negative Breast Cancer, T-cell Acute Lymphoblastic Leukemia, Desmoid Tumors and Multiple Myeloma (in collaboration with Novartis).
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
21
Frequently Asked Questions
What is Market Cap of Ayala Pharmaceuticals Inc?
What is the 52-week high for Ayala Pharmaceuticals Inc?
What is the 52-week low for Ayala Pharmaceuticals Inc?
What is Ayala Pharmaceuticals Inc stock price today?
What was Ayala Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Ayala Pharmaceuticals Inc?
What is the Price-to-Book ratio of Ayala Pharmaceuticals Inc?
What is Ayala Pharmaceuticals Inc's EBITDA?
What is the 50-day moving average of Ayala Pharmaceuticals Inc?
How many employess does Ayala Pharmaceuticals Inc has?